Evidence that Antidepressants Increase the Risk of Suicide

Open letter to Managing Editor Mary K. Billingsley, Journal of the American Academy of Child & Adolescent Psychiatry
Editor Dost Öngür,
JAMA Psychiatry (previously Archives of General Psychiatry)

Call for retraction of three fraudulent trial reports of antidepressants in children and adolescents

We, a Professor emeritus and specialist in internal medicine with expertise in clinical trials, and 10 people who each lost a child or spouse to suicide as a direct consequence of being prescribed an antidepressant drug for a non-psychiatric condition, call for retraction of three fraudulent trial reports of antidepressants in children and adolescents.

The trial reports seriously underreported suicide attempts, other suicidal events, and precursors to suicide and violence on active drug, and exaggerated the benefits of the drugs substantially.

We know this because independent researchers have compared the published trial data with the data in the clinical study reports of the placebo-controlled trials the drug manufactures submitted to the drug agencies to get approval for their drugs for use in depression in children and adolescents.

By retracting the fraudulent trial reports and explaining why in accompanying editorials, you will provide a much needed service to the scientific community and the world’s citizens, which will reduce the risk of additional meaningless suicides in children and young people.

If you don’t act, you will not only sully the reputation of your journals. You will also be seen as being complicit in future suicides caused by antidepressants as a direct harm of these drugs.

We provide below the most important facts, which should make it easy for you to retract the articles and explain why.

Read the full letter here: Open letter about suicides calling for retraction of three fraudulent trials

See also: